MGAT2 and obesity disorder: In this study, we revealed that pharmacological MGAT2 inhibition by CpdB modulated the release of anorectic gut peptides and intake of an HFD in normal mice and showed a beneficial effect on improvement of obesity and diabetes in HFD‐ob/ob mice.